ClinicalTrials.gov
ClinicalTrials.gov Menu

P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03288493
Recruitment Status : Recruiting
First Posted : September 20, 2017
Last Update Posted : August 8, 2018
Sponsor:
Information provided by (Responsible Party):
Poseida Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 31, 2018
  Estimated Study Completion Date : June 30, 2021